First Personal Financial Services Astrazeneca PLC Transaction History

First Personal Financial Services

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 04, 2022	BUY	$54.02 - $63.83 $54 - $63	1 New	1 $0
Q1 2021 Apr 29, 2021	SELL	$47.16 - $54.44 $9,762 - $11,269	-207 Closed	0 $0
Q4 2020 Feb 01, 2021	BUY	$48.52 - $58.02 $10,043 - $12,010	207 New	207 $10,000
Q3 2019 Oct 15, 2019	SELL	$40.12 - $45.47 $46,779 - $53,018	-1,166 Closed	0 $0
Q2 2019 Jul 29, 2019	SELL	$37.28 - $41.68 $3,206 - $3,584	-86 Reduced 6.87%	1,166 $48,000
Q4 2018 Jan 30, 2019	BUY	$36.86 - $41.49 $1,216 - $1,369	33 Added 2.71%	1,252 $48,000
Q3 2018 Nov 01, 2018	BUY	$34.76 - $39.72 $7,230 - $8,261	208 Added 20.57%	1,219 $48,000
Q2 2018 Aug 07, 2018	SELL	$34.55 - $37.05 $88,689 - $95,107	-2,567 Reduced 71.74%	1,011 $35,000
Q1 2018 May 10, 2018	SELL	$32.97 - $36.63 $17,309 - $19,230	-525 Reduced 12.8%	3,578 $126,000
Q4 2017 Jan 25, 2018	BUY	$32.09 - $34.78 $22,463 - $24,346	700 Added 20.57%	4,103 $142,000
Q3 2017 Nov 01, 2017	BUY	$28.96 - $34.0 $98,550 - $115,702	3,403	3,403 $115,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of First Personal Financial Services, based on Form 13F filings with the SEC.

Stay updated on First Personal Financial Services with notifications on news.